Company / R&D per Share
Tango Therapeutics, Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.23
FY2025
5-year range
$0.89 / $1.41
FY2021-FY2025
Trend
-12.9%
vs FY2024
Sector context
#138 of 208
Health Care
What the data says
At $1.23, Tango Therapeutics, Inc.'s r&d per share ranks #138 of 208 in the Health Care sector. Declined from $1.31 to $1.23 over the past 2 years.
Based on SEC 10-K filings.
1.23 in FY2025 with a 5-year CAGR of -4.8%.
Declined from $1.31 to $1.23 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- -4.8%
- 10-Year CAGR
- -
Sector benchmark
#138 of 208 in Health CareTop 66% of 208This company $1.23 Sector average $28.82
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 12.9% year-over-year.
- Ranks #138 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.23 | -12.9% |
| FY2024 | $1.41 | +7.8% |
| FY2023 | $1.31 | +47.2% |
| FY2022 | $0.89 | -28.3% |
| FY2021 | $1.24 | -20.9% |
| FY2020 | $1.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026